|Tags||Global collaboration, HTS, Imaging, Prediction, Quality, Reproducibility, Small Molecules|
In a recent perspective EATRIS addresses the role of global collaborations in preclinical translation in search of system-wide productivity gains. Given the increasing complexity of the biomedical innovation pipeline, collaboration across organizational, sectoral and national boundaries is an increasingly important means of leveraging resources and mitigating risk. By better sharing the costs and risks of developing the tools that help us make better drugs, we can improve the cost effectiveness of R&D without sacrificing competitiveness, thereby delivering more value to patients and payors. Read more about the specific activities that EATRIS and its collaborators are pursuing in this area following this link to the original paper in Clinical and Translational Science.